1. Home
  2. IPSC vs AGFY Comparison

IPSC vs AGFY Comparison

Compare IPSC & AGFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • AGFY
  • Stock Information
  • Founded
  • IPSC 2019
  • AGFY 2016
  • Country
  • IPSC United States
  • AGFY United States
  • Employees
  • IPSC N/A
  • AGFY N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • AGFY Military/Government/Technical
  • Sector
  • IPSC Health Care
  • AGFY Consumer Discretionary
  • Exchange
  • IPSC Nasdaq
  • AGFY Nasdaq
  • Market Cap
  • IPSC 49.6M
  • AGFY 50.6M
  • IPO Year
  • IPSC 2021
  • AGFY 2021
  • Fundamental
  • Price
  • IPSC $0.56
  • AGFY $22.36
  • Analyst Decision
  • IPSC Strong Buy
  • AGFY
  • Analyst Count
  • IPSC 5
  • AGFY 0
  • Target Price
  • IPSC $3.33
  • AGFY N/A
  • AVG Volume (30 Days)
  • IPSC 1.2M
  • AGFY 19.5K
  • Earning Date
  • IPSC 08-07-2025
  • AGFY 08-13-2025
  • Dividend Yield
  • IPSC N/A
  • AGFY N/A
  • EPS Growth
  • IPSC N/A
  • AGFY N/A
  • EPS
  • IPSC N/A
  • AGFY N/A
  • Revenue
  • IPSC $114,898,000.00
  • AGFY $10,218,000.00
  • Revenue This Year
  • IPSC $1,064.82
  • AGFY N/A
  • Revenue Next Year
  • IPSC N/A
  • AGFY N/A
  • P/E Ratio
  • IPSC N/A
  • AGFY N/A
  • Revenue Growth
  • IPSC 8286.72
  • AGFY 9.42
  • 52 Week Low
  • IPSC $0.34
  • AGFY $2.71
  • 52 Week High
  • IPSC $3.29
  • AGFY $84.44
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 46.47
  • AGFY 42.58
  • Support Level
  • IPSC $0.52
  • AGFY $19.75
  • Resistance Level
  • IPSC $0.60
  • AGFY $21.75
  • Average True Range (ATR)
  • IPSC 0.04
  • AGFY 1.97
  • MACD
  • IPSC -0.01
  • AGFY -0.55
  • Stochastic Oscillator
  • IPSC 25.19
  • AGFY 15.66

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About AGFY Agrify Corporation

Agrify Corp is a developer of branded inventive solutions for the cannabis and hemp industries. Its Senorita brand offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror cocktails like a margarita - in three flavors - classic Lime Jalapeno Margarita, Mango Margarita, and Paloma. In addition to beverages, Agrify has also historically been a provider of inventive cultivation and extraction solutions for the cannabis industry. Its comprehensive extraction product line, which includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates.

Share on Social Networks: